Genespire
  • About us
    • The company
    • Management Team
    • Board of Directors
    • Founders
    • Investors
  • Our science
    • Overview
    • Programs
  • News and Events
    • News
  • Contact
  • IT
  • EN
Select Page

Genespire and SR-Tiget announce strategic alliance for the development of transformative gene therapies for genetic diseases and disclose collaboration focus

by Harry Fowler | May 13, 2020 | News

Genespire Secures €16 Million Series A Financing from Sofinnova Partners to Advance Transformative Gene Therapies

by Harry Fowler | Apr 1, 2020 | News

Next Entries »

Genespire Srl

Genespire’s mission is to enable children affected by genetic diseases to benefit from the life-changing potential of gene therapy.

Legal Address

Via Visconti di Modrone, 18
20122 Milano
Italy

e-mail: info@genespire.com

Useful links

  • Privacy Policy
  • Cookie Policy
  • Credits

This site uses only technical cookies and does not perform any profiling or collection of personal data through cookies. Simply browsing the site does not require the user’s consent.
© GENESPIRE Srl. All rights reserved. VAT: 11231080968